Jet Lag Disorder
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Vanda PharmaceuticalsWASHINGTON, DC
2 programsTransmeridian travel across multiple time zonesN/A1 trial
TasimelteonPHASE_21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Vanda PharmaceuticalsTasimelteon
Vanda PharmaceuticalsTransmeridian travel across multiple time zones
Clinical Trials (2)
Total enrollment: 144 patients across 2 trials
A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
Start: Jul 2016Est. completion: Nov 201725 patients
Phase 2Completed
An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
Start: Sep 2015Est. completion: Oct 2017119 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.